» Authors » C Gandin

C Gandin

Explore the profile of C Gandin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 407
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Widmann C, Gandin C, Petit-Paitel A, Lazdunski M, Heurteaux C
Sci Rep . 2018 Dec; 8(1):18062. PMID: 30584250
Inflammation is considered as a major contributor to brain injury following cerebral ischemia. The therapeutic potential of both MLC601/MLC901, which are herbal extract preparations derived from Chinese Medicine, has been...
2.
Lorivel T, Gandin C, Veyssiere J, Lazdunski M, Heurteaux C
J Neurosci Res . 2015 Mar; 93(11):1648-63. PMID: 25821139
MLC901 (NurAiDII) is used as a treatment for stroke patients. It has been shown that MLC901 improves motor and cognitive recovery in ischemic and traumatic brain-injured rodents. The present study...
3.
Quintard H, Lorivel T, Gandin C, Lazdunski M, Heurteaux C
Neuroscience . 2014 Jul; 277:72-86. PMID: 24993477
Traumatic brain injury (TBI) is a frequent and clinically highly heterogeneous neurological disorder with large socioeconomic consequences. NeuroAid (MLC601 and MLC901), a Traditional Medicine used in China for patients after...
4.
Heurteaux C, Widmann C, Moha Ou Maati H, Quintard H, Gandin C, Borsotto M, et al.
Cerebrovasc Dis . 2013 Apr; 35 Suppl 1:1-7. PMID: 23548913
Background: Treatments for stroke and other brain injuries are limited. NeuroAiD has been shown to be beneficial in clinical studies. We reviewed the pharmacological effects of NeuroAiD on the normal...
5.
Scafato E, Galluzzo L, Ghirini S, Gandin C, Rossi A, Solfrizzi V, et al.
Psychol Med . 2012 Apr; 42(12):2619-29. PMID: 22490118
Background: Depression is recognized as being associated with increased mortality. However, there has been little previous research on the impact of longitudinal changes in late-life depressive symptoms on mortality, and...
6.
Moha Ou Maati H, Veyssiere J, Labbal F, Coppola T, Gandin C, Widmann C, et al.
Neuropharmacology . 2011 Aug; 62(1):278-88. PMID: 21807005
Despite several decades of research, current antidepressant (AD) treatments remain of a limited efficacy justifying the need to find new drugs. These drugs have to be more efficacious, more rapid...
7.
Quintard H, Borsotto M, Veyssiere J, Gandin C, Labbal F, Widmann C, et al.
Neuropharmacology . 2011 May; 61(4):622-31. PMID: 21605573
Global ischemia leads to damage in the hippocampal CA1 region and is associated with behavioral deficits. NeuroAid (MLC601 and MLC901), a Traditional Chinese Medicine is used in China for patients...
8.
Heurteaux C, Gandin C, Borsotto M, Widmann C, Brau F, Lhuillier M, et al.
Neuropharmacology . 2010 Jan; 58(7):987-1001. PMID: 20064536
Although stroke remains a leading cause of death and adult disability, numerous recent failures in clinical stroke trials have led to some pessimism in the field. Interestingly, NeuroAid (MLC601), a...
9.
Nguemeni C, Delplanque B, Rovere C, Simon-Rousseau N, Gandin C, Agnani G, et al.
Pharmacol Res . 2009 Dec; 61(3):226-33. PMID: 20036742
Populations of Western countries are severely deficient in omega-3 intake, both in the form of alpha-linolenic acid (ALA) and the Long Chain derivatives (LC-n-3), Eicosa-Pentaenoic-Acid and Docosa-Hexaenoic-Acid. Omega-3 insufficiency is...
10.
Casini A, Mohamed E, Gandin C, Tarantino U, Di Daniele N, De Lorenzo A
Dig Liver Dis . 2004 Jan; 35(12):881-7. PMID: 14703884
Background: Chronic liver diseases, including cirrhosis of the liver, have been shown to cause bone osteometabolic disease giving rise to osteoporosis and osteomalacia. Aims: To develop mathematical prediction equations for...